↓ Skip to main content

The Development and Psychometric Properties of the MSQOL

Overview of attention for article published in Clinical Drug Investigation, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
22 Mendeley
Title
The Development and Psychometric Properties of the MSQOL
Published in
Clinical Drug Investigation, August 2012
DOI 10.2165/00044011-199815050-00006
Pubmed ID
Authors

Stephen P. McKenna, Lynda C. Doward, Kate Mackenzie Davey

Abstract

This paper describes the development and testing of the UK version of the Migraine-Specific Quality-of-Life instrument (MSQOL), a measure designed to assess the quality of life of migraineurs. The work was part of an international research study conducted in eight countries, with the initial development work conducted in the UK and the USA. In the UK, interviews were held with 30 patients with migraine, while in the USA, 25 individual interviews were conducted, along with one focus group with 5 participants. Transcripts were produced of the interviews/group discussion and these were used to determine the questionnaire items, which were then considered by an international translation panel. The panel considered the feasibility of translating the items into other European languages. The instrument was then assessed for reliability and validity. The UK version of the MSQOL was shown to have excellent test-retest reliability (0.93 over 2 weeks) and internal consistency (0.92 and 0.93 on the first and second administrations, respectively). Scores on the measure were also found to be related to a comparator measure of well-being and to perceived severity of migraine and disruption caused to patients by the disease. Findings for the other language versions of the MSQOL supported those from the UK, suggesting that the instrument may well be suitable for inclusion in clinical trials.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 21 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 36%
Professor > Associate Professor 3 14%
Student > Ph. D. Student 2 9%
Student > Bachelor 1 5%
Student > Master 1 5%
Other 3 14%
Unknown 4 18%
Readers by discipline Count As %
Medicine and Dentistry 5 23%
Psychology 4 18%
Agricultural and Biological Sciences 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Linguistics 1 5%
Other 2 9%
Unknown 7 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2013.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Clinical Drug Investigation
#318
of 1,035 outputs
Outputs of similar age
#64,208
of 187,813 outputs
Outputs of similar age from Clinical Drug Investigation
#94
of 344 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,035 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,813 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.